Mr. Dwight Gorham reports

INTELGENX TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS ON AUGUST 14, 2023 - CONFERENCE CALL TO FOLLOW

IntelGenx Technologies Corp. will release its second quarter 2023 financial results after market close on Monday, Aug. 14, 2023.

An accompanying conference call will be hosted by Dwight Gorham, chief executive officer, Andre Godin, president and chief financial officer, and Dr. Horst G. Zerbe, chairman, to discuss the results and provide a business update. Details of the conference call and webcast are below.

Second quarter 2023 results conference call details

Date:  Monday, Aug. 14, 2023

Time:  4:30 p.m. ET

Live call:  1-888-506-0062 (Canada and the United States) or 1-973-528-0011 (international)

Access code:  570916

The call will also be broadcast live and archived on the company's website under webcasts in the investors section.

About IntelGenx Technologies Corp.

IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.

IntelGenx's superior film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allow for next-generation pharmaceutical products that address unmet medical needs. IntelGenx's innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions.

IntelGenx's highly skilled team provides comprehensive pharmaceutical services to pharmaceutical partners, including research and development, analytical method development, clinical monitoring, intellectual property, and regulatory services. IntelGenx's state-of-the-art manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production.

We seek Safe Harbor.